RobecoSam USA’s Pfizer PFE Stock Holding History

RobecoSam USA’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,959	Closed	-$265K	–	69
2014 Q4	$265K	Sell	8,959 -12,081	-57%	-$346K	0.29%	62
2014 Q3	$590K	Buy	21,040 +2,575	+14%	+$72.3K	0.65%	36
2014 Q2	$520K	Hold	18,465	–	–	0.57%	42
2014 Q1	$563K	Hold	18,465	–	–	0.64%	36
2013 Q4	$537K	Sell	18,465 -5,821	-24%	-$169K	0.58%	38
2013 Q3	$662K	Buy	24,286 +2,139	+10%	+$58.2K	0.85%	34
2013 Q2	$589K	Buy	+22,147	New	+$612K	0.83%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RobecoSam USA's PFE Position: Q1 2015 in Review

RobecoSam USA sold out of Pfizer (PFE) in Q1 2015, closing a stake of 8,959 shares — an estimated $265K sold.

RobecoSam USA first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $662K in Q3 2013. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

RobecoSam USA reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
RobecoSam USA sold 8,959 Pfizer shares in Q1 2015, an estimated $265K.
RobecoSam USA first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
RobecoSam USA's Pfizer position peaked at $662K in Q3 2013.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on RobecoSam USA's 13F filing for Q1 2015, filed 5 May 2015.